132 related articles for article (PubMed ID: 37886056)
1. Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India.
Gopalaswamy R; Kumar N; Vashistha H; Rajendran P; Kayesth J; Peravali CJ; Kashyap S; Ghosh S; Yumo H; Moore M; Anand S; Ramachandran R; Alavadi U; Saini S; Shanmugam S
Front Public Health; 2023; 11():1255756. PubMed ID: 37886056
[TBL] [Abstract][Full Text] [Related]
2. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients.
Gomathi NS; Singh M; Myneedu VP; Chauhan DS; Tripathy S; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; V Rao MV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Singh UB
Indian J Med Res; 2020 Nov; 152(5):482-489. PubMed ID: 33707390
[TBL] [Abstract][Full Text] [Related]
3. Performance evaluation of Truenat MTB and Truenat MTB-RIF DX assays in comparison to gene XPERT MTB/RIF ultra for the diagnosis of pulmonary tuberculosis in Uganda.
Ssengooba W; Katamba A; Sserubiri J; Semugenze D; Nyombi A; Byaruhanga R; Turyahabwe S; Joloba ML
BMC Infect Dis; 2024 Feb; 24(1):190. PubMed ID: 38350885
[TBL] [Abstract][Full Text] [Related]
4. Multicentric validation of indigenous molecular test Truenat™ MTB for detection of
Gomathi NS; Singh M; Singh UB; Myneedu VP; Chauhan DS; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; Rao MVV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Tripathy S
Indian J Med Res; 2020 Oct; 152(4):378-385. PubMed ID: 33380702
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of the Truenat MTB Plus Assay and Comparison with the Xpert MTB/RIF Assay to Detect Tuberculosis among Hospital Outpatients in Cameroon.
Ngangue YR; Mbuli C; Neh A; Nshom E; Koudjou A; Palmer D; Ndi NN; Qin ZZ; Creswell J; Mbassa V; Vuchas C; Sander M
J Clin Microbiol; 2022 Aug; 60(8):e0015522. PubMed ID: 35861529
[TBL] [Abstract][Full Text] [Related]
6. A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays.
Penn-Nicholson A; Gomathi SN; Ugarte-Gil C; Meaza A; Lavu E; Patel P; Choudhury B; Rodrigues C; Chadha S; Kazi M; Macé A; Nabeta P; Boehme C; Gangakhedkar RR; Sarin S; Tesfaye E; Gotuzzo E; du Cros P; Tripathy S; Ruhwald M; Singh M; Denkinger CM; Schumacher SG; ;
Eur Respir J; 2021 Oct; 58(5):. PubMed ID: 34049948
[TBL] [Abstract][Full Text] [Related]
7. Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF.
Singh UB; Singh M; Sharma S; Mahajan N; Bala K; Srivastav A; Singh KJ; Rao MVV; Lodha R; Kabra SK
Sci Rep; 2023 Apr; 13(1):6976. PubMed ID: 37117209
[TBL] [Abstract][Full Text] [Related]
8. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
Boehme CC; Nicol MP; Nabeta P; Michael JS; Gotuzzo E; Tahirli R; Gler MT; Blakemore R; Worodria W; Gray C; Huang L; Caceres T; Mehdiyev R; Raymond L; Whitelaw A; Sagadevan K; Alexander H; Albert H; Cobelens F; Cox H; Alland D; Perkins MD
Lancet; 2011 Apr; 377(9776):1495-505. PubMed ID: 21507477
[TBL] [Abstract][Full Text] [Related]
9. The New Xpert MTB/RIF Ultra: Improving Detection of
Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
[TBL] [Abstract][Full Text] [Related]
10. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia.
Meaza A; Tesfaye E; Mohamed Z; Zerihun B; Seid G; Eshetu K; Amare M; Sinshaw W; Dagne B; Mollalign H; Diriba G; Getu M; Yenew B; Tadesse M; Fikadu D; Abebaw Y; Moga S; Kebede A; Tola HH; Alemu A; Getahun M; Gumi B
PLoS One; 2021; 16(12):e0261084. PubMed ID: 34962949
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Diagnostic Accuracy Study of Abbott RealTi
Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
[TBL] [Abstract][Full Text] [Related]
14. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
15. Impact and operational feasibility of TrueNat
Jeyashree K; Shanmugasundaram D; Rade K; Gangakhedkar RR; Murhekar MV
Public Health Action; 2020 Sep; 10(3):87-91. PubMed ID: 33134121
[TBL] [Abstract][Full Text] [Related]
16. Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population.
Raizada N; Sachdeva KS; Swaminathan S; Kulsange S; Khaparde SD; Nair SA; Khanna A; Chopra KK; Hanif M; Sethi GR; Umadevi KR; Keshav Chander G; Saha B; Shah A; Parmar M; Ghediya M; Jaju J; Boehme C; Paramasivan CN
PLoS One; 2015; 10(10):e0140375. PubMed ID: 26469691
[TBL] [Abstract][Full Text] [Related]
17. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
[TBL] [Abstract][Full Text] [Related]
19. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
Rachow A; Zumla A; Heinrich N; Rojas-Ponce G; Mtafya B; Reither K; Ntinginya EN; O'Grady J; Huggett J; Dheda K; Boehme C; Perkins M; Saathoff E; Hoelscher M
PLoS One; 2011; 6(6):e20458. PubMed ID: 21738575
[TBL] [Abstract][Full Text] [Related]
20. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.
Haraka F; Kakolwa M; Schumacher SG; Nathavitharana RR; Denkinger CM; Gagneux S; Reither K; Ross A
Cochrane Database Syst Rev; 2021 May; 5(5):CD012972. PubMed ID: 34097769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
